Angene Chemical
Draw
|
Currency :
Home Products

AG00IBRZ

68-41-7 | (4R)-4-amino-1,2-oxazolidin-3-one

Chemical structure of (4R)-4-amino-1,2-oxazolidin-3-one, CAS 68-41-7
AG00IBRZ
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 68-41-7
Catalog Number AG00IBRZ(AGN-PC-0OGK0N)
Chemical Name (4R)-4-amino-1,2-oxazolidin-3-one
EC Number 200-688-4
IUPAC Name (4R)-4-amino-1,2-oxazolidin-3-one
InChI InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1
InChI Key DYDCUQKUCUHJBH-UWTATZPHSA-N
MDL Number MFCD00005353
Molecular Formula C3H6N2O2
Molecular Weight 102.0919
NSC Number 756712
SMILES N[C@H]1C(NOC1)=O
UNII 95IK5KI84Z
Synonyms
Cycloserine, R-4-Amino-3-isoxazolidinone, Seromycin, D-cycloserine, cycloserine, 68-41-7, Seromycin, orientomycin, Oxamycin, Cyclorin, Cyclo-D-serine, Cicloserina, Farmiserina, Miroseryn, Tisomycin, Wasserina, Closina, D-4-amino-3-isoxazolidinone, (R)-4-AMINOISOXAZOLIDIN-3-ONE, alpha-Cycloserine, (+)-4-Amino-3-isoxazolidinone, Cycloserinum, Miroserina, D-4-amino-3-isoxazolidone, Oxamicina, (4R)-4-aminoisoxazolidin-3-one, PA 94, (+)-Cycloserine, (4R)-4-amino-1,2-oxazolidin-3-one, Oxamicina [Italian], Cycloserin, Micoserina, Cicloserina [Italian], PA-94, Tebemicina, Novoserin, (R)-4-AMINO-ISOXAZOLIDIN-3-ONE, D-Oxamycin, RO-1-9213, D-CS, Cycloserinum [INN-Latin], E-733-A, Cicloserina [INN-Spanish], D-4-Amino-3-isossazolidone, D-(+)-Cycloserine, 3-Isoxazolidinone, 4-amino-, (R)-, HSDB 3218, D-Oxamicina, 3-Isoxazolidinone, 4-amino-, d-, K-300, UNII-95IK5KI84Z, (R)-(+)-4-Amino-3-isoxazolidinone, I-1431, 3-Isoxazolidinone, 4-amino-, (+)-, D-4-Amino-3-isossazolidone [Italian], NSC 154851, 3-Isoxazolidinone, 4-amino-, (4R)-, (R)-4-Amino-3-isoxazolidinone, CHEBI:40009, AI3-50153, D-Cycloserine, synthetic, EINECS 200-688-4, MFCD00005353, CHEMBL771, BRN 0080798, Closerin, SC-49088, 95IK5KI84Z, DYDCUQKUCUHJBH-UWTATZPHSA-N, CAS-68-41-7, NCGC00016306-01, D-Cycloserine, 98%, DSSTox_CID_2870, 3-Isoxazolidinone, 4-amino-, (+)- (8CI), DSSTox_RID_76766, DSSTox_GSID_22870, Cycloserine, D-, .alpha.-Cycloserine, (R)-Cycloserine, Seromycin (TN), 4AX, CPD000058313, SMR000058313, R-4-Amino-3-isoxazolidinone, Cycloserine [INN:BAN:JAN], (S)-(-)-Cycloserine, R-(+)-Cycloserine, (4R)-4-Amino-3-isoxazolidinone, 4-Amino-isoxazolidin-3-one, SR-01000075432, DRG-0195, (R)-(+)-Cycloserine, D-Cycloserine synth. BP 88, D-amino-3-isoxazolidinone, (R)-4-Amino-3-isoxazolidone, Serine, cyclo-, 3-Isoxazolidinone, 4-amino-, D, R(+)-4-Amino-3-isoxazolidinone, Cycloserine [USP:INN:BAN:JAN], 3-Isoxazolidinone, 4-amino-, (R), PubChem5763, D-Cycloserine, powder, Spectrum_000860, 1pb9, CYCLOSERINE (D), Prestwick0_001089, Prestwick1_001089, Prestwick2_001089, Prestwick3_001089, Spectrum2_000084, Spectrum3_000371, Spectrum4_000305, Spectrum5_000797, Lopac-C-1159, Lopac-C-3909, Lopac-C-7005, 3-Isoxazolidinone, 4-amino-, (4R)- (9CI), C 3909, C-9390, C-9400, AC1Q4UA7, Lopac0_000252, SCHEMBL34322, BSPBio_001138, BSPBio_002121, KBioGR_000890, KBioSS_001340, 4-27-00-05549 (Beilstein Handbook Reference), MLS000758215, MLS001423962, MLS002548887, BIDD:GT0707, DivK1c_000098, SPECTRUM1500215, SPBio_000008, SPBio_003029, AC1L1M33, BPBio1_001252, FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09, GTPL9489, Cycloserine (JP17/USP/INN), 4-Amino-3-isoxazolidinone, D-, DTXSID8022870, HMS500E20, KBio1_000098, KBio2_001340, KBio2_003908, KBio2_006476, KBio3_001341, NINDS_000098, HMS1571I20, HMS1920C06, HMS2051C15, HMS2091I14, HMS2098I20, HMS2232F03, HMS3259L19, HMS3260D06, HMS3715I14, NJ-21, Pharmakon1600-01500215, R (+)-4-amino-3-isoxazolidinone, (R)-3-Isoxazolidinone, 4-amino-, 4-Amino-3-isoxazolidinone, (R)-, ACT04767, HY-B0030, KS-00001FB7, Tox21_110361, Tox21_500252, BDBM50038178, BDBM50103516, CCG-39705, D-Cycloserine, >=96.0% (NT), FC1270, LMPK14000007, NSC756712, s1998, ZINC34676245, 4-Isoxazolidinamine, 3-oxo-, (D)-, AKOS015994626, Tox21_110361_1, AC-4721, CS-2395, DB00260, HS-0079, LP00252, MCULE-4212827696, NC00050, NC00676, NSC-756712, RL04615, IDI1_000098, SMP1_000167, NCGC00015213-01, NCGC00015213-02, NCGC00015213-03, NCGC00016306-02, NCGC00016306-03, NCGC00016306-04, NCGC00016306-05, NCGC00016306-07, NCGC00016306-08, NCGC00093713-01, NCGC00093713-02, NCGC00260937-01, AJ-89953, AN-11678, BR-26256, CAS-339-72-0, K138, LS-86757, SAM001247014, SAM002264599, SC-06256, ST075697, SBI-0050240.P004, AB0007232, AB2000415, ST2408171, AB00443920, EU-0100252, FT-0624464, (4R)-4-amino-2,4,5-trihydroisoxazol-3-one, C08057, D00877, AB00443920_09, AB00443920_10, 005C353, 101039-EP2295402A2, 101039-EP2301544A1, SR-01000759389, SR-01000075432-1, SR-01000075432-2, SR-01000075432-5, SR-01000075432-9, SR-01000759389-4, SR-01000075432-10, F2173-1228, Z1522567171, Cycloserine, United States Pharmacopeia (USP) Reference Standard, Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material, L-Cycloserine, Levcycloserine, Oxymycin, DL-Cycloserine, 4-Amino-3-isoxazolidinone, 4-Aminoisoxazolidin-3-one, D02WFK, D04TMQ, D0G6RT, D-Cycloserine, 98% 1g, C3H6N2O2, cc-130, Cycloserine [BAN:INN:JAN], Cycloserine (JP15/USP/INN), CID6234, D-Cycloserine, 98% - 1G 1g, C3-H6-N2-O2, c1189, NSC154851, (R)-4-amino-1,2-oxazolidin-3-one, ACN-034126, CS-O-01140, 3-Isoxazolidinone, 4-amino-, (+)-(8CI), 3-isoxazolidinone, 4-amino-, (4r)-(9ci), B1721, A10291, M-3650, D003523, DCS, 339-72-0, 68-39-3,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited